Results 161 to 170 of about 8,387 (243)

Trimetazidine and reperfusion injury [PDF]

European Heart Journal, 2001
openaire   +1 more source

Cardiovascular Implications of the Enhanced Games: Performance Enhancing Drugs in Competition and Recreation. [PDF]

Sports Med Open
Vecchiato M, Palermi S, Zamodics M, Babity M, Eftekhari M, Ryali R, Luk J, Taseh A, Ashkani-Esfahani S, Merkely G, Juhasz V.   +10 more
europepmc   +1 more source

Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer. [PDF]

Mol Cancer
He C, Wang D, Hu T, Gonzalez D, Thakur R, Matysniak DP, King RJ, Kollala SS, Markov SD, Fujii Y, Tej GNVC, Zhao J, Jin L, Oberley-Deegan R, Shukla SK, Zhang XA, Friedman JE, Singh PK, Hollingsworth MA, di Magliano MP, Crawford HC, Mehla K.   +21 more
europepmc   +1 more source

Trimetazidine-Profen Hybrid Molecules: Synthesis, Chemical Characterization, and Biological Evaluation of Their Racemates. [PDF]

Pharmaceuticals (Basel)
Dimitrova D, Manolov S, Ivanov I, Bojilov D, Dimova N, Marc G, Oniga S, Oniga O.   +7 more
europepmc   +1 more source

Guanxinjing ameliorates coronary microvascular dysfunction in myocardial ischemia-reperfusion injury by alleviating inflammation and restoring endothelial function. [PDF]

Front Immunol
Wang Y, Li L, Jin L, Zhan S, Ren H, Zhao J, Wang Q, Wang Y, Lin S, Xin J, Dai Y, Zhou Y, Zhang T, Liu Q, Lu Y, Zhu Y, Wu J, Lin J, Zhang S, Zhang L.   +19 more
europepmc   +1 more source

Cardiologists' Diagnostic and Therapeutic Approaches in the Outpatient Management of Patients with Chronic Coronary Syndrome in Turkey: An Observational-Registration Study. [PDF]

J Cardiovasc Dev Dis
Arslan A, Ozkaya OG, Aytemiz F, Küçükukur M, Asiltürk E, Iyigün U, Bayram M, Fedai H, Koç Ş, Malkoç D, Doğduş M, Kümet Ö, Bayrak M, Öztürk Ö, Koçak A, Ömür SE, Bekar L, Kayhan Ö, Katkat F, Öztürk C, Yeşil E, Akgümüş A, Balun A, Erdoğan A, Kunak AÜ, Toprak K, Er F, Serin E, Çalışkan S, İnci S, Zoghi M.   +30 more
europepmc   +1 more source

Wenxin Keli regulates energy metabolism and improves Cx43 via the AMPK/SIRT1/PGC-1α pathway. [PDF]

Front Pharmacol
Cui X, Lou L, Nie B, Zhao Y, Zhao J, Yang D, Wang Z, Zheng S, Wu A.   +8 more
europepmc   +1 more source

Evaluation of the Potential Benefits of Trimetazidine in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial. [PDF]

Pharmaceuticals (Basel)
Youssif M, Eid RA, Rabea H, Madney YM, Khaled A, Orayj K, Attia D, Wahsh EA.   +7 more
europepmc   +1 more source

Acute-on-chronic liver failure-associated CD45⁺ EPCs reduced survival via promoting fatty acid β-oxidation in vascular endothelial cells. [PDF]

Cell Mol Life Sci
Li X, Zhang N, Pang XQ, Wu HS, Yu CY, Huang ZX, Xing YF, Gao ZL.   +7 more
europepmc   +1 more source

Evaluating cardioprotective strategies for anthracycline-induced cardiotoxicity in breast cancer: insights from a systematic review and network meta-analysis. [PDF]

Cardiooncology
Liu R, Fan C, Liu X, Li M, Zhang Y, Zhang M.   +5 more
europepmc   +1 more source